Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Systematic Approaches and Progressive Therapies to treat Parkinsons and Movement disorders
- Parkinsons 2020

Welcome Message

Pleasant welcome back to all for the 2nd International Conference on Parkinson's, Huntington's & Movement Disorders in association/collaboration with Allied Academies that frames thepast, cherish the present and mould the future to be slated on March 25-26,2020 at Amsterdam, Netherlands.

This year with a refreshing theme as Systematic Approaches andProgressive Therapies to treat Parkinson’s and Movement Disorders to underpin the wide range of professionals in the field of neuroscience, neurology and neurosurgery.

Parkinsons 2020 is your best opportunity to reach the largest assemblage ofparticipants around the globe. Join, conduct presentations, exchange informationand connect with the current eminent and potential scientists to explore moreon neurosurgery, central nervous system, neuropharmacology and neurodegenerative disorders,make an impact with new innovations, developments and receive name recognitionand certificates signed by our world-class eminent organizing committee at thistwo days event. World-renowned speakers, the most advanced and recent techniques,developments and the newest updates in Neurology and the Neurological Disorders are hallmarks at this conference.

Join us the exclusive Parkinsons 2020, the unique convention to bring together worldwide distinguished industrialistsand academicians in the field of Neuroscience, Neurology, Neurosurgery, NeurologicalDisorders, Neurodegenerative disorders, Novel Therapeutics, Neuro-physiotherapy, Nanomedicine, Neuropharmacology, Nursing and more.

Meet and Explore at Amsterdam, Netherlands!

Regards

Organizing Committee

Parkinsons 2020

About Conference

Parkinsons 2020 welcomes attendees, presenters, andexhibitors from all over the world to Amsterdam. We are delighted to invite youall to attend and register for our upcoming “2nd International Conference on Parkinson's, Huntington's & Movement Disorders” which is going to be held during March 25-26, 2020 at Amsterdam, Netherlands.

Parkinsons 2020
has been designed in an interdisciplinary manner with a multitude oftracks to choose from every segment and provides you with a unique opportunityto meet up with peers from both industry and academia and establish ascientific network between them. We cordially invite all concerned people tocome to join us at our event and make it successful by your participation.

At Allied Group, It is our ideology to bring maximum exposure to ourattendees, so we make sure the event is a blend that covers professionals suchas Neurosurgeons, Scientists, Neurologists, Doctors, Professors, DiagnosticLaboratory Professionals from academia & industry making the
Parkinsons 2020 Annual Meeting a perfect platform.

The conference will be organized around the Theme ‘Systematic Approachesand Progressive Therapies to treat
Parkinsons and Movement disorders’. Our goal is todeliver an outstanding program that covers the entire spectrum of research &innovations in Neurology, care and share the cross-cultural experiences of various treatmentprocedures.

Parkinsons 2020
is an annual meeting of Neurological and Neurological Professionals aswell as committees to discuss the future of the Neurological Disorders in terms of collaboration, structures and organizational development.

Parkinsons 2020 Highlights:

200+ Participation (40% Industry:60% Academia)
9+ Keynote Speakers
30+ Plenary Speakers
3+ Exhibitors
14 Innovative Educational Sessions
B2B Meetings

Why to attend???

With members from around the world focused on learning about
Parkinson’s and Huntington’sDisorders and its advances; this is your best opportunity toreach the largest assemblage of participants from the Neurological Community.Conduct presentations, distribute information, meet with current and potentialscientists, make a splash with new discoveries in the Neurological treatmentand diagnosis, and receive name recognition at this 2-day event. World-renownedspeakers, the most recent techniques, developments, and the newest updates inthe field of Neurological disorders and its various treatments.

Scientific Sessions

Session onParkinson’s Disease


Parkinson’s Disease is a chronic and progressive disease of the nervoussystem and it became worse over time. It is the second most common neurologicaldisorder. In ordinary Conditions, nerve cells exhibit in cerebrum and deliversa neurotransmitter called dopamine that oversees a development, feelings, andco-appointment yet because of unhealthy individual dopamine creation, hence theindividual end up with control the development ordinarily. In Germany, has alifetime prevalence of between 0.1 and 0.3% of the population.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society ofIndiaAustralian Parkinson’s DiseaseSocietyMovement Disorder Society ofJapan

Session onEpidemiology of Parkinson’s disease


Parkinson’s is one of the well-known age connected neurodegenerative disorder, in return simply to Alzheimer's disease.  There areapproximately seven Million individuals affected with Parkinson’s globally.Several studies and theories are considering the danger factors and theprotecting measures for the onset of the Parkinson, though the results wereimperfect and foreseeable. The neuroepidemiology of PD is very complex withsusceptibility genes and several modifiable risk factors that can increase andothers that can mitigate risks and outcomes.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society ofIndiaAustralian Parkinson’s DiseaseSocietyMovement Disorder Society ofJapan

Session onDiagnosis of Parkinson’s Disease

The identification of PD is difficult in earlier stages, it goes on atthe end the result is not obtained. There is no direct treatment for PD andthere is no biopsy reports or scan reports that confirm the diagnosis. Atpresent, there is no cure for PD. Medication is given in 3 stages: Initialstage includes the drug called Levodopa, which increase the monoamineneurotransmitter in the brain, the second stage shows less severe PD symptomsand the third stage will help to manage the non-motor symptoms as well asdepression. Magnetic Resonance Imaging and Computed Tomogram are used by manyphysicians to find out other relating Parkinson’s diseases such asencephalitis, Tumours, Hydrocephalus. Dopamine level release and activity ofthe brain can easily detect using PET and SPECT examining.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society ofIndiaAustralian Parkinson’s DiseaseSocietyMovement Disorder Society ofJapan

Session onInsights and therapeutics: Parkinson’s disease

The introduction about Levodopa and the demonstration that dopamine lossis the key pathological feature of PD have revolutionized the field of PDtherapeutics. In most cases of Parkinson’s disease, protein deposits calledLewy Bodies. It is unclear whether Lewy bodies play an important role inkilling nerve cells or just part of the cells which are responsible to theParkinson’s disease. Nearly 15 percent of people with PD have motor symptomsthat are not controlled with levodopa. A group of drugs that act directly ondopaminergic reports called dopamine against is used as adjuncts to levodopa inthe treatment of PD.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society ofIndiaAustralian Parkinson’s DiseaseSocietyMovement Disorder Society ofJapan

Session onParkinson’s Disease complications

Parkinson’s disease is not a life-threatening condition. With time, the illnesswill bring more problems with speech, movement, and brain functioning.Parkinson’s disease is usually accompanied by additional problems, which may becured, and they are thinking difficulties, swallowing, depression and emotionalchanges, sleep difficulties, constipation, blood pressure changes, fatigue,pain, and some complications are Insomnia, Urinary Incontinence, Paraesthesia.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society ofIndiaAustralian Parkinson’s DiseaseSocietyMovement Disorder Society ofJapan

Session onPathophysiology and Pharmacology

Parkinson’s disease is originated from the gradual loss of cells in thesubstantia nigra of the brain. This is mainly responsible for the assembly ofneurotransmitter. Dopamine is a neurotransmitter which transmits signalsbetween two regions of the brain to coordinate activities like the movement oflimbs. If there is a deficiency in dopamine production results in loss ofcoordination and end up with the symptoms of Parkinson’s Disease. The diseaseprogresses, various areas of the brain and nervous system degenerate to bootinflicting a lot of movement disorder.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society ofIndiaAustralian Parkinson’s DiseaseSocietyMovement Disorder Society ofJapan

Session onClinical Trials in Parkinsonism

To develop a drug or treatment for Parkinson’s disease observationalstudy is being conducted by a scientist in a laboratory to provide patientswith a better life. Clinical trials are performed to slow down the rate ofsuffering and reduce the symptoms. There is no cure for PD as far, butresearchers improved more treatment. Trails help to reduce the risk factors. Trailsare the best way to find out whether a new treatment is safe, is a benefit to patients,is more effective, is that improving the quality of life with PD

Clinical research is an expensive process which requires strongfinancial support. This comes from a range of sponsors including thepharmaceutical industries, Governments, Researchers, and Organisations.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onFree Radicals and Aging in Parkinson’s

Free radicles have both beneficial and baleful effect on human bodyparts. Oxidative stress is known to cause many neurological disorders such asAlzheimer’s, Parkinson’s and Amyotrophic Lateral Sclerosis. With oldness, thereis a typical failure of the dopamine-producing neurons. In some of the raresituation’s symptoms are seen in children and terms is referred to as JuvenileParkinsonism.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onManaging life with Parkinson’s disease

It is important to develop a PD management plan because it is a chronicdisease. The individual should get practiced maintaining the stress levels anddepression by daily communicating with close people, friends, colleagues.Patients can improve life by following Instructions given by the counsellor.Managing life with PD includes building a healthcare team with proper Doctors,proper intake of medications, exercises, nutritional drink, and proper sleep.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onRisk Factors of Parkinson’s Disease

Risk factors for the PD mainly depend on age, hereditary, sex andexposure to toxins. The causes of the diseases are believed to be eithergenetic or environmental. Symptoms and progression of disease will not be thesame among the suffering individuals but people with Parkinson’s are at ahigher rate of developing related risks. Parkinson’s disease has a chance ofcreating mental ailment which can be mild or serious. It includes cognition,mood, behavior which are considered as major impairment when compared to normalpopulational. The common mood swings seen in the patients are despair,eagerness, indifference Melanoma, Neurogenic, Orthostatic Hypotension,Executive dysfunction, Orthostatic hypertension. Now a day’s Head Injury andGene variation are in addition to an element of PD.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onNeurodegenerative Diseases

Neurodegeneration is the progressive loss of structure or function ofneurons, including the death of neurons. Many neurodegenerative diseases –including Parkinson's disease, Alzheimer's disease, and Huntington'sdisease and amyotrophic lateral sclerosis, – occur as a result ofneurodegenerative processes. The greatest risk factor for neurodegenerativediseases is aging. Mitochondrial DNA mutations as well as oxidative stress bothcontribute to aging. Many of these diseases are late onset, meaning there issome factor that changes as a person ages for each disease. One constant factoris that in each disease, neurons gradually lose function as the diseaseprogresses with age. It has been proposed that DNA damage accumulation providesthe underlying causative link between aging and neurodegenerative disease.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onHuntington’s Disease

Huntington’s disease (HD) is a fatal genetic disorder usually inheritedfrom Parents and often many describe the symptoms of HD as having Parkinson’sand Alzheimer’s disease simultaneously. Symptoms usually appear between theages of 30 to 50 and worsen over a 10 to 25 every year. The weak people tend tohave pneumonia, Heart failure, and other complications. Every person whoinherits the expanded HD gene will eventually develop the Huntington disease.Over a period, HD affects the individual’s ability to reason, walk and speak.In approximately 10% of cases have HD in children or adolescents. The symptomsof Juvenile HD are somewhat different than adult-onset HD and it includesStiffness or awkward walking, increased clumsiness and changes in speech. Theability of learning skills may tend to decline, and the child may lose skills.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onBradykinesia

According to studies more than men, women were mostly affected byBradykinesia. It is a reduced pace in bodily movements of a person. Parkinson’shas four key symptoms, in that Bradykinesia is one among them. Parkinson’s isalso called "Idiopathic parkinsonism", meaning parkinsonism with noidentifiable cause.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onAtaxia

Ataxia is a degenerative disease of the nervous system. Many symptoms ofAtaxia can mimic those of being drunk - slurred speech, stumbling, falling, andincoordination. All are related to degeneration of the part of the brain,called the cerebellum that is responsible for coordinating movement. Ataxia isa disease that affects people of all ages. Age of symptom-onset canvary widely, from childhood to late adulthood. Complications from the diseaseare serious, oftentimes debilitating, and can be life-shortening. Ataxia is anumbrella term used to classify a group of diseases that include: AtaxiaTelangiectasia, Episodic Ataxia, Friedreich’s Ataxia, Multiple System Atrophy,Spinocerebellar Ataxia, Sporadic Ataxia.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onAphasia

Aphasia is an inability to comprehend or formulate language becauseof damage to specific brain regions. This damage is typically caused by acerebral vascular accident (stroke), or head trauma; however, these are not theonly possible causes. In Aphasia, a person's speech or language will besignificantly impaired in one (or several) of the four communication modalitiesfollowing acquired by brain injury or have significant decline over a shorttime period. The four communication modalities are auditory comprehension,verbal expression, reading and writing, and functional communication.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onAlzheimer’s Disease & Dementia

Alzheimer’s is caused by cerebrum cell demise and it is a neurologicalissue in which the demise of cerebrum cells causes memory misfortune andintellectual decrease. Dementia is a general form term for a decline in abilitysevere enough to interface with daily life. Alzheimer’s is the most common typeof dementia. Memory loss is an example. The disease progress in differentstages: Early, Moderate and Advanced stages. Early stage is Tremor, it is thefirst symptom. As it continues it will lead to Dementia in few cases. Some ofthe complications include Dementia of Alzheimer’s Disease, Treatment ofAlzheimer’s Disease, Stroke related Dementia, Young onset Dementia.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onPediatric Movement disorders

It is a moderately new and developing field of child neurology. Thereare many genetic diseases which cause secondary movement disorder in childhood.Propels in paediatric movement disorder have been made by solidifying movementdisorder definitions, growing the range of phenotypes, understanding geneticreasons for movement disorders, and thoroughly assessing treatment adequacy fornormal movement disorder. The central nervous system typically implicated indisorders of movements are the basal and frontal cortex.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onNeuromuscular Disorders and Neural transplantation

Neurons are responsible for communication when they cannot producesignals communication between nervous system breaks and result in neuromusculardisorders. Some of them are ALS, Multiple sclerosis, Alzheimer’s disease,Spinal Muscular Atrophy. Neural transplantation is the transplantation of nervecells, tissues into the brain and spinal cord. The cell replacement for PD isbased on two hypothesis- firstly the early symptoms of PD are dependent on theloss of the dopaminergic neurons in the nigrostriatal pathways and secondly thedopaminergic neurons are gathered into dopamine deficient striatum can replacethose neurons which has been lost during the disease process and can reversesome extent of the major symptoms of PD. Some of the therapies are NeuralGrafting, Transplantation therapy, Cell Transplantation, Rebuilding of DopamineCircuit

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15, 2019at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session onNeurosurgery

Presently Deep brain stimulator is widely recommended for improvingpeople suffering from Parkinson’s disease. There will be no effect by using DBSto healthy brain tissue by terminating nerve cells. Instead of that, theprocedure blocks electrical signals from targeted areas in the brain.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Session on: Novel Therapeutics

The most used drug for treating Parkinson’s disease is Levodopa whichhas a higher frequency to develop motor fluctuations and results in L-dopainduced dyskinesia (LID). Researchers propose novel ideas to treat Parkinson’sdisease to decrease the risk of causing side effects, the frequency ofdyskinesia, to treat cognitive disorders such as Anxiety and depression.

Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology  Conference

Related Conferences:

6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological Society;  European Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of IndiaAustralian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Market Analysis

Parkinson’s diseasemarket is set to expand from $2.2 billion in 2014 to $3.3 billion by 2021, at amoderate Compound Annual Growth Rate (CAGR) of 5.8 percent, game-changingtreatments will not be available for the future, according to businessintelligence provider GBI Research. There are approximately 10 millionindividuals experiencing Parkinson's infection all around theworld. Parkinson's,as far it has a higher recurrence in the created nations.

In Worldwide, itis estimated that 6.3 million people have PD with no differentiation for raceand culture. The age of onset is usually over 60-65, but it is estimated thatone in ten are diagnosed before the age of 50, and it can affect people intheir 40’s and younger.

According toavailable statistics, 2 million people in Europe have Parkinson’s, whichapproximates to:

260,000 inGermany

200,000 in Italy

150,000 in Spain

120,000 in UK

117,000 inFrance.

PD makes thesecond most common neurodegenerative disorder, that is it equates to a rate ofmore than 1 per 1000 people in Europe.

It is difficultto tell how common Huntington’s Disease HD is in a populationacross the world. In Western Countries, it’s estimated that about five to ninepeople per 100,000 are affected by HD. A high population of HD has also beenfound in the Lake Maracaibo region of Venezuela where the prevalence of HD isabout 700 per 100,000.

For more detailsplease visit: parkinsons.alliedacademies.com

ConferenceHighlights:

Parkinson’s Disease

Epidemiology of Parkinson’s disease

Diagnosis of Parkinson's disease

Insights and therapeutics: Parkinson’s disease

Parkinson's disease Complications

Pathophysiology and Pharmacology

Clinical trials in parkinsonism

Free radicals and aging in parkinsonism

Managing life with Parkinson's disease

Risk factors of Parkinson’s disease

Huntington’s Disease

Bradykinesia

Alzheimer’s disease and Dementia

Pediatric movement disorder

Neuromuscular Disorder

Neurosurgery

Novel Therapeutics

Target Audience

Neurologists,Psychiatrists, Psychologists, Neurosurgeon, Director, Industries, Delegates,Clinical Specialists, Physicians, Neuroscientists,  Community members,Lectures and Students from various Academics, Professors, Researchers,Scientists, Therapists.

MajorAssociations around the Globe

National Parkinson Foundation

American Parkinson Disease Association (APDA)

Parkinson’s disease Foundation

Movement Disorder Society of Australia

Parkinson's Unity Walk

Movement Disorder Society of Japan

Moroccan Neurological Society Movement Disorders Group

Italian Society for the Study of ParkinsonDisease, Extrapyramidal Diseases, and Dementia

Ecuador Movement Disorders Group

Austrian Parkinson's Disease Society

Danish Movement Disorder Society

Top universities500 globally working in the field of Parkinson's Disease

University of Bath

The University of Queensland

University of Bristol

University of Cambridge

The Imperial College of Science and Medicine

Duke University

University of Milan

Karolinska Institute

University of Hamburg

The University of Edinburgh

University of Munich

University of Rochester

University of Zurich

Leiden University

University of Bristol

University of Helsinki

Uppsala University

University of Freiburg

University of Frankfurt

Organizing Committee
OCM Member
John M. Baumann
University of Louisville
Louisville, USA
OCM Member
Dr Chan Hong Park
Chairman, Neurosurgery/ Spine Surgery
Daegu Wooridul Spine Hospital
Incheon, South Korea
OCM Member
Dr. Tatsuo Ido
Chaired person & Director, Pharmaceutical Science
Gachon University
Incheon, South Korea
OCM Member
Irene Treacy
Director of Smovey Health
Smovey Health
Dublin, Ireland
OCM Member
George Perry
Dean
The University of Texas
Houston, USA
OCM Member
Dr Rodney Leacock
Director of Neuroscience ICU , Neuroscience
Palmetto Health-USC Medical Group
Bogota, Colombia
OCM Member
Eric M. Massicotte
Neurosurgeon ,MD, MSc, FRCS(C) , Neurosurgery
University of Toronto
Toronto, Canada
OCM Member
Walter Bini
Consultant Neurosurgeon, Orthopedic Department
Healthpoint Hospital
Dubai, United Arab Emirates
OCM Member
Dr.Elena Frid
Neurologist
Robert Wood Johnson Medical School
Jersey, USA
Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
parkinsons@alliedtalk.com
Sponsors/Exhibiting/Advertising
parkinsons@neurologymeeting.com
General Queries
More details about sponsorship:sponsors@alliedacademies.com

Highlights from last year's Convention

Authorization Policy

Copyright © 2020-2021 Allied Academies, All Rights Reserved.